RxHub Names New CEO
This article was originally published in The Pink Sheet Daily
RxHub Chief Operating Officer David McLean, PhD, is taking over as CEO of the pharmacy benefit management industry electronic prescribing company
You may also be interested in...
Specific patient information should be provided at the point of care, Pfizer tells the HHS subcommittee charged with setting e-prescribing standards. Express Scripts prefers providing formulary and copay data, rather than actual cost information.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.